Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82.8M
-
Number of holders
-
215
-
Total 13F shares, excl. options
-
45.7M
-
Shares change
-
+600K
-
Total reported value, excl. options
-
$1.35B
-
Value change
-
+$25.7M
-
Put/Call ratio
-
1.78
-
Number of buys
-
112
-
Number of sells
-
-61
-
Price
-
$29.61
Significant Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q4 2019
256 filings reported holding EDIT - Editas Medicine, Inc. - Common Stock as of Q4 2019.
Editas Medicine, Inc. - Common Stock (EDIT) has 215 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.7M shares
of 82.8M outstanding shares and own 55.25% of the company stock.
Largest 10 shareholders include Nikko Asset Management Americas, Inc. (4.95M shares), Sumitomo Mitsui Trust Holdings, Inc. (4.95M shares), VANGUARD GROUP INC (4.57M shares), ARK Investment Management LLC (4.45M shares), BlackRock Inc. (4.24M shares), STATE STREET CORP (1.99M shares), Capital World Investors (1.76M shares), FEDERATED HERMES, INC. (1.44M shares), D. E. Shaw & Co., Inc. (1.41M shares), and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.16M shares).
This table shows the top 215 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.